01718nam 2200433 450 991071530160332120210315103151.0(CKB)5470000002511023(OCoLC)1241690737(EXLCZ)99547000000251102320210315d2021 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierRisk of transmitting COVID-19 during nebulizer treatment a living ultra-rapid review /Karen M. Goldstein [and ten others]Updated January 2021.Washington, DC :Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service,2021.1 online resource (ii, 31 pages) color illustrationsEvidence synthesis programIncludes bibliographical references (pages 20-23).Risk of transmitting COVID-19 during nebulizer treatment AtomizersUnited StatesCOVID-19 (Disease)TransmissionUnited StatesRespiratory infectionsTreatmentUnited StatesRespiratory agentsUnited StatesAtomizersCOVID-19 (Disease)TransmissionRespiratory infectionsTreatmentRespiratory agentsGoldstein Karen M.1353976United States.Department of Veterans Affairs.Health Services Research and Development Service,GPOGPOBOOK9910715301603321Risk of transmitting COVID-19 during nebulizer treatment3483832UNINA